Efficacy and Safety Following Use of a Novel Nicotine Replacement Therapy

• Status: Completed
• Trial end date: 2010-06-01
• Target enrollment: 0
• Participant gender: All

Summary

A comparison of a novel nicotine replacement therapy and placebo treatment in smokers motivated to quit smoking.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: McNeil AB
• Treatments: Nicotine

Criteria

Inclusion Criteria:

• 18 years or older male and female cigarette smokers motivated and willing to stop smoking

• Female participants of child-bearing potential should use a medically acceptable means of birth control.

• Evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study and consents to participate.

Exclusion Criteria:

• Unstable angina pectoris or myocardial infarction during the previous 3 months.

• Pregnancy, lactation or intended pregnancy (non-pregnancy will be verified by urine pregnancy test for female participants of child-bearing potential).

• Participation in other clinical trials within the previous three months and during study participation.